Jain, P., Kantarjian, H., Patel, K. P., Gonzalez, G. N., Luthra, R., Shamanna, R. K., . . . Cortes, J. (2016). Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors. Blood.
استشهاد بنمط شيكاغوJain, Preetesh, et al. "Impact of BCR-ABL Transcript Type On Outcome in Patients With Chronic-phase CML Treated With Tyrosine Kinase Inhibitors." Blood 2016.
MLA استشهادJain, Preetesh, et al. "Impact of BCR-ABL Transcript Type On Outcome in Patients With Chronic-phase CML Treated With Tyrosine Kinase Inhibitors." Blood 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.